AQSZF (Aequus Pharmaceuticals) Net Margin %: 146.70% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aequus Pharmaceuticals Net Margin %?

Aequus Pharmaceuticals AQSZF Net Margin % is 146.70% as of Sep. 2025. The stock has 6 warning signs investors should review. Among 962 Drug Manufacturers companies, Aequus Pharmaceuticals ranks worse than 89.09% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Aequus Pharmaceuticals's Net Income for the three months ended in Sep. 2025 was $0.27 Mil. Aequus Pharmaceuticals's Revenue for the three months ended in Sep. 2025 was $0.18 Mil. Therefore, Aequus Pharmaceuticals's net margin for the quarter that ended in Sep. 2025 was 146.70%.

The historical rank and industry rank for Aequus Pharmaceuticals's Net Margin % or its related term are showing as below:

AQSZF' s Net Margin % Range Over the Past 10 Years
Min: -1162.75   Med: -232.61   Max: -40.3
Current: -71.49

AQSZF's Net Margin % is ranked worse than
89.09% of 962 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs AQSZF: -71.49

Aequus Pharmaceuticals  (OTCPK:AQSZF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aequus Pharmaceuticals Net Margin % Related Terms

Aequus Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Aequus Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aequus Pharmaceuticals Net Margin % Chart

Aequus Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.32 -66.67 -232.58 -1,163.16 -372.93

Aequus Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -416.51 -98.08 -284.18 -75.47 146.70

AQSZF vs GCAN, STEK, CBSTQ: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's Net Margin % falls into.


Aequus Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aequus Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.529/0.41
=-372.93 %

Aequus Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2025 is calculated as

Net Margin=Net Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=0.267/0.182
=146.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 146.70% mean?
Aequus Pharmaceuticals (AQSZF) has a Net Margin % of 146.70% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Aequus Pharmaceuticals and its competitors. According to the industry distribution chart, Aequus Pharmaceuticals ranks #857 out of 962 companies in the Drug Manufacturers industry, placing it in the top 89.1%.
Is Aequus Pharmaceuticals' Net Margin % too high?
Aequus Pharmaceuticals' current Net Margin % is 146.70%. The Drug Manufacturers industry median Net Margin % is 5.56. Aequus Pharmaceuticals' value of 146.70% is 2538.5% above this industry median. Based on the distribution chart, Aequus Pharmaceuticals ranks #857 out of 962 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Aequus Pharmaceuticals' Net Margin % compare to GCAN and STEK?
According to the Drug Manufacturers industry distribution chart, Aequus Pharmaceuticals ranks #857 out of 962 companies for Net Margin %. This places Aequus Pharmaceuticals in the lower half of its industry. The industry median Net Margin % is 5.56. Aequus Pharmaceuticals' value of 146.70% is 2538.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aequus Pharmaceuticals's current Net Margin % of 146.70% is 2538.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aequus Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aequus Pharmaceuticals's current Net Margin % is 146.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aequus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Aequus Pharmaceuticals (AQSZF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 74% below its estimated fair value. The current Net Margin % is 146.70% and 2538.5% above the Drug Manufacturers industry median of 5.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aequus Pharmaceuticals (AQSZF), the current Net Margin % is 146.70% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aequus Pharmaceuticals Business Description

Address 200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.